Melanin concentrating hormone receptor antagonist

Details for Australian Patent Application No. 2004266233 (hide)

Owner Amgen, Inc.

Inventors Hulme, Christopher; Balow, Guity; Ma, Vu; Tempest, Paul; Nixey, Thomas

Agent EF WELLINGTON & CO

Pub. Number AU-A-2004266233

PCT Pub. Number WO2005/019167

Priority 60/494,735 13.08.03 US

Filing date 11 August 2004

Wipo publication date 3 March 2005

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/019167 Priority application(s): WO2005/019167

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266242-Tie1-binding ligands

2004266232-Mitotic kinesin inhibitors